Nucl Med Mol Imaging.  2007 Apr;41(2):132-140.

Imaging of Dopaminergic System in Movement Disorders

Affiliations
  • 1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea. kse@snu.ac.kr

Abstract

Parkinson's disease is a common neurodegenerative disorder that is mainly caused by dopaminergic neuron loss in the substantia nigra. Several radiopharmaceutics have been developed to evaluate the integrity of dopaminergic neuronal system. In vivo PET and SPECT imaging of presynaptic dopamine imaing are already applied to Parkinson's disease and other parkinsonism, and can demonstrate the dopaminergic dysfunction. This review summarized the use of the presynaptic dopaminergic imaging in PD as biomarkers in evaluation of disease progression as well as in diagnosis of PD.

Keyword

Parkinson's disease; dopaminergic system; biomarker

MeSH Terms

Biomarkers
Diagnosis
Disease Progression
Dopamine
Dopaminergic Neurons
Movement Disorders*
Neurodegenerative Diseases
Parkinson Disease
Parkinsonian Disorders
Substantia Nigra
Tomography, Emission-Computed, Single-Photon
Dopamine
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr